The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...

Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...

Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...

Billions of dollars are pouring into longevity startups as a growing body of research shows that aging might not be as inevitable as we assumed. Now, a startup claims to have reached a major milestone ...

A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...